Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

Author： Herrstedt J.   Sigsgaard TC   Nielsen HA   Handberg J.   Langer SW   Ottesen S.   Dombernowsky P.  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.15, Iss.4, 2007-04, pp. : 417-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

By Garcia-del-Muro X.   Vadell C.   Perez Manga G.   Bover I.   Rifa J.   Beltran M.   Barros M.a.M.   Germa J.R.   Fabregat X.   Moreno V.   Salvador A.   Viladiu P.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 193-195

Elsevier

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite

Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy in Patients with Acute Emesis: A Pilot Study with ACTH-Depot Plus Tropisetron

By Santini D.   Vincenzi B.   Fossati C.   D'Angelillo R.M.   Patti G.   Bianco V.   Avvisati G.   Tonini G.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 131-135

Humana Press, Inc

Access to resources Recommend Favorite